Navigation Links
Capital BlueCross CEO Says Meaningful Statewide Competition Must Be Key Criteria in Pennsylvania's Review of Proposed Highmark-IBC Merger
Date:1/30/2008

a purported $1 billion, one-time economic benefit to the Commonwealth. I know this Committee will carefully review that figure. But it also should carefully review what it would have to give up for that money. Pennsylvania's health-insurance market will account for more than $500 billion over the next decade alone. So we respectfully pose the question -- is a one-time payment worth mortgaging the competitive future of this enormous and vital market?

"We believe the answer is no. But what is beyond debate is this: To approve this merger without competition-enhancing conditions would forever close the door on a competitive statewide health-insurance marketplace. Make no mistake: This merger is the Commonwealth's final opportunity. We either nurture vibrant statewide competition. Or we forever preclude it."

For a copy of CEO Smith's testimony, please go to http://www.capbluecross.com.

Capital BlueCross is an independent licensee of the Blue Cross and Blue Shield Association


'/>"/>
SOURCE Capital BlueCross
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...ether procedure done immediately or 3 weeks later,...ay News) -- Timing of surgical repair or reconstru...ffect patient outcome, a new study has found. ,...atic knee dislocations that can occur in high-impa...ime to perform surgery to repair these injuries ha...
(Date:12/4/2009)...N, Dec. 4 Substantial progress has...e community,s ability to diagnose and treat epilep...ilepsy management has not reached most of the 50 m...the nearly three million people in the United Stat...n C. Schachter, M.D., president of the American Ep...
(Date:12/4/2009)... virus will come back during winter isn,t known, C...News) -- The number of states reporting widespread... -- to 25 from a high of 48 just two weeks ago, a ...the supply of H1N1 swine flu vaccine continues to ....S. Centers for Disease Control and Prevention, sa...
(Date:12/4/2009)...edge of risks, many hesitate to take breast cancer...ealthDay News) -- Worries about side effects are a... at high risk for breast cancer are willing to tak... study finds. , In an effort to inform women ab...rs at the University of Michigan Comprehensive Can...
(Date:12/4/2009)...DISON, Wis., Dec. 4 When... Wisconsin Department of Health Services needed to...than ever before. Join Sonic Foundry, Inc. (Nasd... media webcasting and knowledge management, for a ...n Department of Health Services, will share how in...
Breaking Medicine News(10 mins):Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Swine Flu Continues to Wane 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
... Scientists with the Lineberger Comprehensive Canc...hapel Hill have for the first time implicated a g... the inevitable recurrence of advanced prostate ca...es prostate cancer recur in men treated to get rid...
... Researchers at the University of Wisconsin-Madiso... of measuring molecular structures quickly and ac...ld and see the shapes of intermediate steps. ...n that is implicated in type II diabetes. ...
... When compared with intensive drug therapy, percut...s more beneficial in reducing the long-term risk ...rs with 'silent ischemia', according to a study. ...oms of angina (chest pain due to inadequate supply...
... A new study has found that no other lifestyle fac.... A study in the May issue of the Journal ...t have the most impact on periodontal health. ...ferent lifestyle factors on the progression of per...
... A research on animals, conducted by the National ...ence that a chemical referred to as hexavalent chr...med in drinking water. Hexavalent chromiu...The two-year study showed that the mice had develo...
... A review has suggested that women who take a low-...ting, have a reduced risk of pregnancy complicati...31 studies involving more than 32,000 women, found... that women need to be cautious, especially as asp...
Other Medicine News:Health News:Study Implicates Protein as a Trigger of Advanced Prostate Cancer Recurrence 2Health News:New Analytical Tool to Unravel the Cause of Diabetes 2Health News:Angioplasty Reduces Long-term Cardiac Risk in Heart Patients With 'silent' Ischemia 2Health News:Impact of Periodontal Health High With Smoking and Sleeping 2
(Date:12/4/2009)..., Dec. 4 Dynatronics Cor...a sole-source vendor agreement to provide therapy ... Therapy with 65 clinics located in Tennessee and ...le-source supplier to Benchmark Physical Therapy,"...of sales and marketing at Dynatronics. "Benchmark ...
(Date:12/4/2009)...ASHINGTON, Dec. 4 Chem...ublished by the Pharmaceutical Research and Manuf...new drugs and vaccines in development for HIV/AIDS...nd that the 97 products in development include 23 ... in human clinical trials or awaiting approval by ...
(Date:12/4/2009)... Dec. 4 PharmAthene, Inc...ing medical countermeasures against biological and...y is presenting results of a study demonstrating t...n anthrax model in the New Zealand White (NZW) rab...session at the HHS Public Health Emergency Medical...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6NBTY to Web Cast Fiscal Fourth Quarter Conference Call 60597 1NBTY to Web Cast Fiscal Fourth Quarter Conference Call 60597 2Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 1Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 2Ethics and Healthcare Reform Panel Community Forum Open to Public November 17 60593 3Free 2D 3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging 5946 1Free 2D 3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging 5946 2
...detail how some fair coloring traits contribute to... into the deCODEme(TM) service, REYKJAVIK, Icelan...cientists and academic colleagues from Europe and ... in the genetics of pigmentation,traits in people ...of these,common variants also confer risk of two t...
...lmo BioTech Inc. (OTC,Bulletin Board: PLMO.OB) has...of its Phase I Human Trials with its PulmoBind Mol...monary Embolism and Pulmonary,Hypertension., The ...idiary,PulmoScience Inc., and the title of the wor...olecular Imaging of the Pulmonary Circulation.", ...
Other Medicine Technology:deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 3
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: